Venker Eric
Transaction: 07/27/2026
SELL
Change
-200,000
Price
$34.95
Filing
07/29/2026
Type
SELL
Roivant Sciences Ltd.
ROIV • Biotechnology
$34.93
▲ +0.52 (+1.51%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$25.18B
Growth
-29.7%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 18.37Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:21 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$34.93
Change1.51%
Shares Out720.78M
Market Cap$25.18B
Enterprise Value$21.44B
52W Range10.90 - 37.00
Beta1.11
P/E-94.56
P/S3,342.64
P/B5.95
P/FCF-30.66
EV/Sales2,846.76
Price$34.93
Change1.51%
Shares Out720.78M
Market Cap$25.18B
Enterprise Value$21.44B
52W Range10.90 - 37.00
Beta1.11
P/E-94.56
P/S3,342.64
P/B5.95
P/FCF-30.66
EV/Sales2,846.76
EV/EBITDA-15.72
EV/FCF-26.11
Earnings Yield-1.06%
FCF Yield-3.26%
Dividend Yield0.00%
Gross Margin84.44%
Oper. Margin-155.61%
Profit Margin-36.29%
Debt/Eq0.02
Current Ratio18.37
Quick Ratio18.37
Revenue 5Y-29.73%
Target$40.00
Target Upside14.51%
Target Median$41.00
Target Range36.00 - 42.00
Volume7.02M
Avg Volume5.82M
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 18.37Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 15 analyst votes · 2026-09-05
97/100
Bullish
Bullish
14
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$30.00
Mean
$37.17
Median
$38.00
High
$42.00
Insider Transactions
Recent executive and insider activity
⚠ 8 high-volume insider sells detected
Venker Eric
Transaction: 07/27/2026
SELL
Change
-200,000
Price
$3.85
Filing
07/29/2026
Type
SELL
Oren Ilan
Transaction: 07/17/2026
BUY
Change
+775
Price
Not reported
Filing
07/21/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Venker Eric | SELL | -200,000 | $34.95 | 07/27/2026 | 07/29/2026 |
| Venker Eric | SELL | -200,000 | $3.85 | 07/27/2026 | 07/29/2026 |
| Oren Ilan | BUY | +775 | Not reported | 07/17/2026 | 07/21/2026 |
| Epperly Melissa B, | BUY | +543 | Not reported | 07/17/2026 | 07/21/2026 |
| MOMTAZEE JAMES C | BUY | +405 | Not reported | 07/17/2026 | 07/21/2026 |
| Sukhatme Mayukh | SELL | -46,878 | $35.39 | 06/30/2026 | 07/02/2026 |
| Torti Frank | SELL | -40,310 | $35.39 | 06/30/2026 | 07/02/2026 |
| Fitzgerald Meghan | SELL | -10,000 | $8.80 | 06/30/2026 | 07/02/2026 |
| Fitzgerald Meghan | SELL | -10,000 | $34.90 | 06/30/2026 | 07/02/2026 |
| Gline Matthew | SELL | -76,171 | $35.39 | 06/30/2026 | 07/02/2026 |
| Epperly Melissa B, | SELL | -2,748 | $34.71 | 06/29/2026 | 07/01/2026 |
| Epperly Melissa B, | SELL | -17,750 | $4.46 | 06/29/2026 | 07/01/2026 |
| QVT Financial LP | SELL | -12,380 | $35.28 | 06/30/2026 | 06/30/2026 |
| Gold Daniel Allen | SELL | -12,380 | $35.28 | 06/30/2026 | 06/30/2026 |
| MANCHESTER KEITH S | SELL | -200,000 | $35.45 | 06/30/2026 | 06/30/2026 |
| QVT Financial LP | SELL | -600,000 | $34.59 | 06/29/2026 | 06/30/2026 |
| Gold Daniel Allen | SELL | -600,000 | $34.59 | 06/29/2026 | 06/30/2026 |
| MANCHESTER KEITH S | SELL | -600,000 | $34.59 | 06/29/2026 | 06/30/2026 |
| QVT Financial LP | SELL | -325,000 | $34.07 | 06/26/2026 | 06/30/2026 |
| Gold Daniel Allen | SELL | -325,000 | $34.07 | 06/26/2026 | 06/30/2026 |